SCHEMBL1994576

SCHEMBL1994576

OB(O)c1cccc(CN2CCCCC2)c1F

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
KDM4E B2RXH2 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
POLB P06746 1/20 0.49
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
CACNA1B Q00975 1/20 0.40
CHRNA7 P36544 1/20 0.40
TSHR P16473 1/20 0.40
GFER P55789 1/20 0.40
MPO P05164 1/20 0.40
GAA P10253 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29955435 1.00 ALDH1A1 (0.56) ALDH1A1KDM4ESMN1; SMN2POLBMEN1
SCHEMBL2464403 0.83 ALDH1A1 (0.58) ALDH1A1KDM4ESMN1; SMN2POLBMEN1
SCHEMBL29952724 0.83 ALDH1A1 (0.58) ALDH1A1KDM4ESMN1; SMN2POLBMEN1
Hydrochloric Acid SCHEMBL29951165 0.81 ALDH1A1 (0.56) ALDH1A1KDM4ESMN1; SMN2POLBMEN1
Hydrochloric Acid SCHEMBL29956387 0.81 ALDH1A1 (0.56) ALDH1A1KDM4ESMN1; SMN2POLBMEN1
SCHEMBL29504703 0.81 ALDH1A1 (0.55) ALDH1A1KDM4EPOLBMEN1KMT2A
SCHEMBL21352377 0.81 ALDH1A1 (0.55) ALDH1A1KDM4EPOLBMEN1KMT2A
SCHEMBL19367987 0.80 ALDH1A1 (0.59) ALDH1A1KDM4ESMN1; SMN2POLBMEN1
SCHEMBL30341108 0.80 ALDH1A1 (0.73) ALDH1A1KDM4ESMN1; SMN2POLBKMT2A
Hydrochloric Acid SCHEMBL29954918 0.80 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373627-A1 1- (BIPHENYL-4-YLMETHYL) IMIDAZOLIDINE-2, 4-DIONE DERIVATIVES AND THEIR USE AS CB2 RECEPTOR AGONISTS N.V. Organon (NL) 2011-10-12 EP disclosed
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US disclosed
WO-2010063721-A1 1- (BIPHENYL-4-YLMETHYL) IMIDAZOLIDINE-2, 4-DIONE DERIVATIVES AND THEIR USE AS CB2 RECEPTOR AGONISTS N.V. ORGANON (NL) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE OPRM1, OR10J3, OPRD1 ALDH1A1 3054/4885KDM4E 1045/4885SMN1; SMN2 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.